HLA Antibodies in Systemic Lupus Erythematosus
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentre Hospitalier Universitaire, Amiens
About this trial
Patients suffering from autoimmune diseases show false-positive results when anti-HLA antibodies are identified. This false positivity makes it difficult to obtain an organ transplant based on immunological compatibility (absence of anti-HLA antibodies directed against graft antigens). The objectives of this project are to study the prevalence of these false positivities in a population of lupus patients, and to evaluate biological tests that can negate these false positivities.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients Adults
Followed in the internal medicine department of Amiens University Hospital - With systemic lupus erythematosus
Without HLA immunization risk factors (no history of pregnancy, transfusions or transplants)
With sera stored in the biobank
Disqualifiers
minor Patients
Opposing the re-use of their personal data for research purposes
Trial population
Patients Adults - Followed in the internal medicine department of Amiens University Hospital - With systemic lupus erythematosus - Without HLA immunization risk factors (no history of pregnancy, transfusions or transplants) - With sera stored in the biobank
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
prevalence of unexplained antibody positivity
prevalence of unexplained antibody positivity
Time frame
6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov